# Case of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome Complicated by Sepsis: Challenges in Diagnosis and Management

**Authors:** Hui Li, Meirong Du, Xia Li, Xiaolan Liu

PMC · DOI: 10.7759/cureus.104237 · 2026-02-25

## TL;DR

A rare and severe case of HELLP syndrome combined with sepsis in a pregnant woman is described, highlighting the importance of timely diagnosis and coordinated care.

## Contribution

This case study presents a rare and complex clinical scenario of HELLP syndrome complicated by sepsis, emphasizing diagnostic and management challenges.

## Key findings

- HELLP syndrome was confirmed alongside sepsis caused by Klebsiella pneumoniae and influenza A.
- Multidisciplinary management led to maternal recovery and neonatal survival despite severe complications.
- Prompt sepsis screening and protocolized interventions are critical in such cases to reduce mortality risks.

## Abstract

Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) syndrome, complicated by sepsis, is a rare yet highly lethal obstetric emergency characterized by synergistic endothelial dysfunction and coagulopathy. This condition presents significant diagnostic difficulties because of its similarities with severe preeclampsia and unusual sepsis. We present the case of a 30-year-old primigravida at 28 weeks’ gestation. She was hospitalized for oligohydramnios and mild hypertension, but quickly progressed to experiencing severe epigastric pain, fever, and multiorgan failure. Laboratory tests revealed thrombocytopenia (51 × 10⁹/L), microangiopathic hemolysis with schistocytes, hepatitis (aspartate aminotransferase 995 U/L), and hyperinflammation (interleukin-6 >500 pg/mL, procalcitonin 35.3 ng/mL). HELLP syndrome was confirmed after the exclusion of other thrombotic microangiopathies. Sepsis preceded the development of HELLP syndrome, with Klebsiella pneumoniae bacteremia and influenza A infection identified as the primary etiologies of sepsis. The multidisciplinary management involved emergent cesarean delivery, broad-spectrum antibiotics, plasma transfusion, and immunomodulation, resulting in progressive maternal recovery and neonatal survival despite premature birth. This case highlights the crucial importance of prompt sepsis screening in HELLP patients experiencing swift clinical decline. It also emphasizes the significance of protocolized interventions guided by Sequential Organ Failure Assessment and coordinated multidisciplinary efforts to reduce the combined risks of maternal-fetal mortality.

## Linked entities

- **Diseases:** HELLP syndrome (MONDO:0008585)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** premature birth (MESH:D047928), bacteremia (MESH:D016470), oligohydramnios (MESH:D016104), epigastric pain (MESH:D010146), Klebsiella pneumoniae (MESH:D007710), Organ Failure (MESH:D009102), preeclampsia (MESH:D011225), Hemolysis (MESH:D006461), hepatitis (MESH:D056486), coagulopathy (MESH:D001778), Sepsis (MESH:D018805), HELLP syndrome (MESH:D017359), fever (MESH:D005334), hypertension (MESH:D006973), influenza A infection (MESH:D007251), thrombotic microangiopathies (MESH:D057049), multiorgan failure (MESH:D051437), thrombocytopenia (MESH:D013921), endothelial dysfunction (MESH:D014652)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13025039/full.md

---
Source: https://tomesphere.com/paper/PMC13025039